UT San Antonio
UT Health San Antonio
Newsroom health conditions id
197

Engineering News-Record: $100M Brain Health Hub Rises on Tight Site in San Antonio

Sudha Seshadri, MD, professor and founding director of the Glenn Biggs Institute for Alzheimer’s and Neurogenerative Diseases, and Michael Charlton, PhD, senior vice president of Facilities and Capital Planning and chief facility planning officer, were interviewed for this article.   Read More

Share This Story

UT Health San Antonio-led discovery means IV medication could be taken orally for range of cancer, Alzheimer’s treatments

Major breakthrough could redefine drug discovery, broaden options A research team led by scientists at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) made a major breakthrough with the potential to turn IV drugs into oral treatments for diseases like brain cancer and Alzheimer’s disease. The discovery could reshape how medicines […]

Share This Story

Texas Public Radio: UT Health San Antonio researchers may be able to turn IV drugs into oral treatment for Alzheimer’s

Robert A. Hromas, MD, FACP, dean of the Joe R. and Teresa Lozano Long School of Medicine, was quoted in this article.   Read More

Share This Story

Science Magazine: UT Health San Antonio Breakthrough Paves Way for Oral Versions of IV Cancer and Alzheimer’s Drugs

Research by Hong-yu Li, PhD, professor, Department of Pharmacology and the Sam and Ann Barshop Institute for Longevity and Aging Studies, and his colleagues, was featured in this article.   Read More

Share This Story

News-Medical: Major breakthrough could turn IV drugs into oral treatments for brain cancer and Alzheimer’s

Hong-yu Li, PhD, professor, Department of Pharmacology and the Sam and Ann Barshop Institute for Longevity and Aging Studies, and Robert A. Hromas, MD, FACP, dean of the Joe R. and Teresa Lozano Long School of Medicine, were quoted in this article.   Read More

Share This Story

Bioengineer: UT Health San Antonio Breakthrough Paves Way for Oral Versions of IV Cancer and Alzheimer’s Drugs

Research by Hong-yu Li, PhD, professor, Department of Pharmacology and the Sam and Ann Barshop Institute for Longevity and Aging Studies, and his colleagues, was featured in this article.   Read More

Share This Story

Mirage News — UT Health Breakthrough: IV Drugs May Go Oral

Hong-yu Li, PhD, professor, Department of Pharmacology and the Sam and Ann Barshop Institute for Longevity and Aging Studies, and Robert A. Hromas, MD, FACP, dean of the Joe R. and Teresa Lozano Long School of Medicine, were quoted in this article.   Read More

Share This Story

ScienceDaily: IV medication could be taken orally for range of cancer, Alzheimer’s treatments

Hong-yu Li, PhD, professor, Department of Pharmacology and the Sam and Ann Barshop Institute for Longevity and Aging Studies, and Robert A. Hromas, MD, FACP, dean of the Joe R. and Teresa Lozano Long School of Medicine, were quoted in this article.   Read More

Share This Story

yahoo! news: Creating DPRIT in Texas would revolutionize dementia care. UT is ready to help | Opinion

This opinion article by The University of Texas System Chancellor James B. Milliken mentions UT Health San Antonio and the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases.   Read More    

Share This Story

Houston Chronicle: Texas can revolutionize dementia care. UT is ready to help.

This opinion article by The University of Texas System Chancellor James B. Milliken mentions UT Health San Antonio and the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases.   Read More (subscription required)

Share This Story

Subscribe to Dementia